Loading company…
Neurovita develops and sells interventional medical devices for cardiovascular, cerebrovascular and structural heart conditions.
Neurovita researches, develops, manufactures and sells interventional devices for cardiovascular, cerebrovascular and structural heart conditions. Products include the NOVA intracranial drug-eluting stent system and Neuro RX and Neuro LPS balloon catheters. Founded in 2020, the company is based in Suzhou, China, and is a subsidiary of Sino Medical Sciences Technology. In November 2022, it raised CNY 100 million in strategic funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in